OriCiro Genomics, Inc.

NEWS & TOPICS

Latest events and information

2021.07.20 PRESS RELEASES

OriCiro Strengthens Leadership Team with Appointment of Shigemasa Sasaki as COO/CBO and Nasir Kato Bashiruddin as CTO

2021.07.20 PRESS RELEASES

OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology

2020.09.30 PRESS RELEASES

OriCiro Launches World’s First Cell-Free Amplification Technology for Large Circular DNA

2019.04.08 PRESS RELEASES

OriCiro launches with $3.6 Million Series A Financing

SCROLL DOWN

PAGE TOP

TECHNOLOGY & SERVICES TEAM & COMPANY NEWS

OriCiro provides reagent kits for assembly and amplification of large DNA up to 200 kbp for research in academia and public institutions.

OriCiro provides on-demand services to our partners based on our proprietary technologies including a service of creating custom-made libraries of large DNA molecules.

OriCiro offers a license for use of our cell-free assembly and amplification technologies for the purpose of the development and manufacturing of plasmid DNA and synthetic genes.

OriCiro provides reagent kits for assembly and amplification of large DNA up to 200 kbp for research in academia and public institutions.

OriCiro provides on-demand services to our partners based on our proprietary technologies including a service of creating custom-made libraries of large DNA molecules.

OriCiro offers a license for use of our cell-free assembly and amplification technologies for the purpose of the development and manufacturing of plasmid DNA and synthetic genes.

Please turn your device.